RETRACTED ARTICLE: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
Abstract Angiogenesis is a potential target for cancer therapy. We identified a novel signaling pathway that sustains angiogenesis and progression in colorectal cancer (CRC). This pathway is triggered by β1 integrin-mediated adhesion and leads to VEGF-A secretion. The effect is modulated by the huma...
Saved in:
Main Authors: | Olivia Crociani, Francesca Zanieri, Serena Pillozzi, Elena Lastraioli, Matteo Stefanini, Antonella Fiore, Angelo Fortunato, Massimo D'Amico, Marika Masselli, Emanuele De Lorenzo, Luca Gasparoli, Martina Chiu, Ovidio Bussolati, Andrea Becchetti, Annarosa Arcangeli |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2013-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/srep03308 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction Note: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
by: Olivia Crociani, et al.
Published: (2025-01-01) -
Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer
by: Claudia Duranti, et al.
Published: (2025-02-01) -
hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways
by: Yan Yu, et al.
Published: (2025-01-01) -
Correction: hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560.
by: Kieran W Benn, et al.
Published: (2024-01-01) -
Correction: hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560
Published: (2024-01-01)